Encyclopedia of Clinical Neuropsychology

2018 Edition
| Editors: Jeffrey S. Kreutzer, John DeLuca, Bruce Caplan


  • Efrain Antonio GonzalezEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-57111-9_1640

Generic Name


Brand Name



Antidepressants and tricyclic antidepressants

Proposed Mechanism(s) of Action

Boosts neurotransmitters serotonin and norepinephrine/noradrenaline; blocks serotonin transporter; apparently desensitizes both serotonin 1A receptors and beta-adrenergic receptors.


Obsessive-compulsive disorder, depression, cataplexy syndrome, and premature ejaculation.

Off-Label Use

Anxiety, insomnia, and chronic pain.

Side Effects


Paralytic ileus, hyperthermia, lowered seizure threshold and rare seizures, orthostatic hypotension, sudden death, arrhythmias, tachycardia, QTc prolongation, increased intraocular pressure, hepatic failure, extrapyramidal symptoms, mania, and suicidal ideation.


Blurred vision, constipation, increased appetite, urinary retention, dry mouth, nausea, diarrhea, heartburn, strange taste in mouth, weight gain, fatigue, weakness, dizziness, headache, anxiety, nervousness, restlessness, sedation, sexual...

This is a preview of subscription content, log in to check access.

References and Readings

  1. Physicians’ Desk Reference (71st ed.). (2017). Montvale: Thomson PDR.Google Scholar
  2. Stahl, S. M. (2007). Essential psychopharmacology: The prescriber’s guide (2nd ed.). New York: Cambridge University Press.Google Scholar

Additional Information

  1. Free Drug Online and PDA Software. www.epocrates.com.
  2. Free Drug Online and PDA Software. www.medscape.com.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.College of PsychologyNova Southeastern UniversityFort LauderdaleUSA
  2. 2.Utah State UniversityLoganUSA